Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Non-controlling Interest
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 $ 632,602   $ 306 $ (67,858) $ 761,128 $ (994) $ (58,882)   $ (1,098)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     200,326            
Exercise of stock options 3,163   $ 1   3,162        
Issuance of common stock - vesting of restricted stock units (in shares)     479,479            
Issuance of common stock - vesting of restricted stock units 2   $ 2            
Acquisition of business (in shares)     15,755            
Acquisition of business 772       772        
Stock-based compensation expense 12,864       12,864        
Purchase of treasury stock for stock-based tax withholdings (in shares)       (160,456)          
Purchase of treasury stock for stock-based tax withholdings (9,819)     $ (9,819)          
Foreign currency translation gain (loss) 222         222      
Net income (loss) (18,268)           (18,185)   (83)
Balance at period end (in shares) at Mar. 31, 2019     61,934,458 13,277,554          
Balance, at period end at Mar. 31, 2019 621,538   $ 309 $ (77,677) 777,926 (772) (77,067)   (1,181)
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 632,602   $ 306 $ (67,858) 761,128 (994) (58,882)   (1,098)
Increase (decrease) in shareholders' equity                  
Transfer of non-controlling units 0                
Foreign currency translation gain (loss) 334                
Net income (loss) (17,655)                
Balance at period end (in shares) at Jun. 30, 2019     65,415,670 13,345,514          
Balance, at period end at Jun. 30, 2019 853,790   $ 327 $ (83,820) 1,015,578 (660) (76,174)   (1,461)
Balance at period start (in shares) at Dec. 31, 2018     61,238,898 13,117,098          
Balance, at period start at Dec. 31, 2018 632,602   $ 306 $ (67,858) 761,128 (994) (58,882)   (1,098)
Balance at period end (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period end at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) $ (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Balance at period start (in shares) at Mar. 31, 2019     61,934,458 13,277,554          
Balance, at period start at Mar. 31, 2019 $ 621,538   $ 309 $ (77,677) 777,926 (772) (77,067)   (1,181)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     114,109            
Exercise of stock options 1,751   $ 1   1,750        
Issuance of common stock - vesting of restricted stock units (in shares)     182,390            
Issuance of common stock - vesting of restricted stock units 1   $ 1            
Acquisition of business (in shares)     3,184,713            
Acquisition of business 222,484   $ 16   222,468        
Stock-based compensation expense 13,434       13,434        
Purchase of treasury stock for stock-based tax withholdings (in shares)       (67,960)          
Purchase of treasury stock for stock-based tax withholdings (6,143)     $ (6,143)          
Foreign currency translation gain (loss) 112         112      
Net income (loss) 613           893   (280)
Balance at period end (in shares) at Jun. 30, 2019     65,415,670 13,345,514          
Balance, at period end at Jun. 30, 2019 853,790   $ 327 $ (83,820) 1,015,578 (660) (76,174)   (1,461)
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period start at Dec. 31, 2019 867,576 (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     357,974            
Exercise of stock options 3,408   $ 2   3,406        
Issuance of common stock - vesting of restricted stock units (in shares)     398,881            
Issuance of common stock - vesting of restricted stock units 2   $ 2            
Stock-based compensation expense 13,765       13,765        
Purchase of treasury stock for stock-based tax withholdings (in shares)       (130,164)          
Purchase of treasury stock for stock-based tax withholdings (9,199)     $ (9,199)          
Foreign currency translation gain (loss) (3,024)         (3,024)      
Net income (loss) (7,190)           (7,336)   146
Balance at period end (in shares) at Mar. 31, 2020     67,077,561 13,609,164          
Balance, at period end at Mar. 31, 2020 864,197   $ 335 $ (100,164) 1,054,312 (4,773) (84,141)   (1,372)
Balance at period start (in shares) at Dec. 31, 2019     66,320,706 13,479,000          
Balance, at period start at Dec. 31, 2019 $ 867,576 $ (1,141) $ 331 $ (90,965) 1,037,141 (1,749) (75,664) $ (1,141) (1,518)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares) 542,449                
Transfer of non-controlling units $ 771                
Foreign currency translation gain (loss) (1,449)                
Net income (loss) (12,661)                
Balance at period end (in shares) at Jun. 30, 2020     67,396,243 13,652,861          
Balance, at period end at Jun. 30, 2020 $ 873,737   $ 337 $ (103,781) 1,071,502 (3,198) (89,065)   (2,058)
Increase (decrease) in shareholders' equity                  
Accounting Standards Update [Extensible List] us-gaap:AccountingStandardsUpdate201613Member                
Balance at period start (in shares) at Mar. 31, 2020     67,077,561 13,609,164          
Balance, at period start at Mar. 31, 2020 $ 864,197   $ 335 $ (100,164) 1,054,312 (4,773) (84,141)   (1,372)
Increase (decrease) in shareholders' equity                  
Exercise of stock options (in shares)     184,475            
Exercise of stock options 3,275   $ 1   3,274        
Issuance of common stock - vesting of restricted stock units (in shares)     134,207            
Issuance of common stock - vesting of restricted stock units 1   $ 1            
Stock-based compensation expense 13,006       13,006        
Purchase of treasury stock for stock-based tax withholdings (in shares)       (43,697)          
Purchase of treasury stock for stock-based tax withholdings (3,617)     $ (3,617)          
Transfer of non-controlling units 771       910       (139)
Foreign currency translation gain (loss) 1,575         1,575      
Net income (loss) (5,471)           (4,924)   (547)
Balance at period end (in shares) at Jun. 30, 2020     67,396,243 13,652,861          
Balance, at period end at Jun. 30, 2020 $ 873,737   $ 337 $ (103,781) $ 1,071,502 $ (3,198) $ (89,065)   $ (2,058)